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The CCAAT box is a prototypical promoter element,
almost invariably found between 60 and 100 upstream
of the major transcription start site. It is bound and acti-
vated by the histone fold trimerNF-Y.We performed chro-
matin immunoprecipitation (ChIP) on chip experiments
on two different CpG islands arrays using chromatin from
hepatic HepG2 and pre-B cell leukemia NALM-6 cell lines,
with different protocols of probe preparation and label-
ing. We analyzed and classified 239 known or predicted
targets; we validated several by conventional ChIPs with
anti-YB and anti-YC antibodies, in vitro EMSAs, and ChIP
scanning. The importance of NF-Y binding for gene ex-
pression was verified by the use of a dominant negative
NF-YA mutant. All but four genes are new NF-Y targets,
falling into different functional categories. This analysis
reinforces the notion that NF-Y is an important regulator
of cell growth, and novel unexpected findings emerged
from this unbiased approach. (i) A remarkable proportion
of NF-Y targets, 40%, are complex transcriptional units
composed of divergent, convergent, and tandem promot-
ers. (ii) 40–50% of NF-Y sites are not in core promoters but
are in introns or at distant 3 or 5 locations. The abun-
dance of “unorthodox” CCAAT positions highlights an un-
expected complexity of the NF-Y-mediated transcrip-
tional network.
The CCAAT box is a DNA element that controls transcrip-
tional initiation in eukaryotic promoters; recent bioinformatic
studies unambiguously identify it as one of the most wide-
spread. The analysis on 1031 human promoters isolated
through unbiased determination of mRNA start sites suggested
that the CCAAT box or its reverse ATTGG is present in as
many as 67% of promoters (1). A statistical, unbiased analysis
of random octanucleotides on a large 13,000-promoter data set
confirmed that the CCAAT is second only to the Sp1-binding
GC box in terms of abundance, despite the fact that the per-
centage of CCAAT promoters was inferior, 7.5% (2). Further-
more, analysis of cell cycle-regulated genes identified the
CCAAT box as specifically present in promoters of G2/M genes
(3). Most importantly, specific flanking nucleotides emerging
from these studies matched specifically the consensus of the
NF-Y transcription factor. A combination of EMSAs and trans-
fections with highly diagnostic dominant negative vectors im-
plicated NF-Y as the CCAAT activator (4). It is composed of
three subunits, NF-YA, NF-YB, and NF-YC, all necessary for
sequence-specific binding to a G/A, G/A, C, C, A, A, T, C/G, A/G,
G/C consensus. NF-YB and NF-YC contain evolutionarily con-
served histone fold motifs common to all core histones, medi-
ating dimerization, a feature strictly required for NF-YA asso-
ciation and sequence-specific DNA binding (5, 6). In essentially
all cases described so far, the binding of the trimer is important
or essential for transcriptional regulation (7).
NF-Y is considered as a general promoter organizer: thanks
to its histone-like nature, it presets chromatin structure locally
(8), interfacing well with nucleosomes (9), it helps the binding
of neighboring factors (reviewed in Refs. 4 and 5) and attracts
coactivators, such as p300/CREB-binding protein (8, 10). The
location of the CCAAT box is far from random, being positioned
between 60 and 100 in the vast majority of the promoters
analyzed. In general, our knowledge of the anatomy of NF-Y-
binding sites in terms of flanking sequences, position with
respect to transcriptional start sites, and promoter context (6,
11, 12) enables us to make predictions as to whether a gene will
be regulated by NF-Y.
Chromatin Immunoprecipitation (ChIP)1 experiments deter-
mined that NF-Y is bound in vivo before gene activation (10–
13); NF-Y is bound to a transcribing cyclin B1 promoter during
mitosis in HeLa cells (14). Indeed, binding to cell cycle-regu-
lated promoters is not constitutive but is time-regulated, being
found before activation and displaced when promoters are re-
pressed (10). Furthermore, conditional knock-out experiments
of CBF-B (NF-YA) unambiguously determined that the protein
is required for cell proliferation of mouse embryo fibroblasts
and mouse development (15).
The analysis of 130 mammalian CCAAT-containing promot-
ers suggests a prevalence in genes that are active in a tissue- or
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development-specific way and in inducible genes, either by
external stimuli or during the cell cycle (7). Whereas this is
certainly informative, very little information exists as to the
binding to other regions. Finding all genes targeted by a par-
ticular transcription factor is crucial to reconstruct its tran-
scriptional network. To expand our knowledge of NF-Y binding
in vivo, a valuable approach is to use DNA derived from ChIPs
to probe microarrays. DNA arrays have been developed in
which clones derived from a CpG island library have been
spotted (16); CpG islands have long been known to be associ-
ated to regulatory elements in promoters (17) and also else-
where in the genome. They are believed to be mainly associated
to “housekeeping” genes (i.e. genes active in all cells), albeit at
different levels (reviewed in Ref. 18). To gain a wider under-
standing of the NF-Y transcriptional circuitry, we took a high
throughput genomic approach by screening with anti-YB chro-
matin-immunoprecipitated DNA two CpG island arrays.
EXPERIMENTAL PROCEDURES
Chromatin Immunoprecipitation Assay
The procedure for ChIP was essentially as described previously (10)
with some modifications. Rabbit polyclonal anti-YB and anti-YC anti-
bodies were derived by purification of the corresponding sera on affinity
columns containing purified recombinant NF-YB or NF-YC linked to
CnBr-Sepharose (Sigma). Nalm-6 and HepG2 cells, grown in RPMI,
supplemented with 10% fetal calf serum, 2 mM L-glutamine, 50 M
-mercaptoethanol, were treated by adding formaldehyde directly to
tissue culture medium to a final concentration of 1% and incubated for
10 min at room temperature. Approximately 5  106 cells were used for
each immunoprecipitation. Cross-linking reactions were stopped by the
addition of phosphate-buffered saline-glycine to a final concentration of
0.125 M. Cells were washed twice with ice-cold phosphate-buffered
saline, scraped, and centrifuged at 2000 rpm for 2 min. Cells were then
resuspended in cell lysis buffer (5 mM Pipes, pH 8.0, 85 mM KCl, and
0.5% Nonidet P-40) containing protease inhibitors (100 ng/ml aprotinin
and 100 ng/ml leupeptin) and 0.5 mM PMSF and kept on ice for 15 min.
Cells were homogenized using a Dounce homogenizer (B pestel) several
times, and the resultant homogenates were centrifuged at 5000 rpm for
5 min at 4 °C to pellet the nuclei. The pellets were resuspended in nuclei
lysis buffer (50 mM Tris-HCl, pH 8.1, 10 mM EDTA, 0.1% SDS, and 0.5%
deoxycholic acid) containing protease inhibitors and PMSF and kept on
ice for 20 min. The nuclear lysates were sonicated on ice to an average
chromatin length of 2–2.5 kb and then centrifuged at 12,000 rpm for 10
min at 4 °C. The supernatants were incubated in IP buffer (50 mM
Tris-HCl, pH 8.1, 10 mM EDTA, 0.1% SDS, 0.5% deoxycholic acid, and
500 mM LiCl) containing protease inhibitors and PMSF, with Protein
G-agarose (KPL) for 2 h at 4 °C in rotation. After removal of Protein
G-agarose, the precleared lysates were used as soluble chromatin for
ChIP. Chromatin was incubated at 4 °C overnight with 4 g of anti-
NF-YB or anti-NF-YC antibodies. No antibody and anti-FLAG (Sigma)
control samples were included. Immunoprecipitates were recovered by
incubation for 2 h at 4 °C with Protein G-agarose previously precleared
in IP buffer (1 g/l bovine serum albumin, 1 g/l salmon testis DNA,
protease inhibitors, and PMSF). To perform a second immunoprecipi-
tation, 30 l of elution buffer (50 mM NaHCO3, 1% SDS) were added,
and the recovered material was diluted with 270 l of IP buffer. 2 g of
the second antibody were added and incubated at 4 °C overnight. The
recovery proceeded as in the first IP reaction. Reversal of formaldehyde
cross-linking, RNase A, and Proteinase K treatments were performed
as previously described (19).
Data validation was performed with conventional ChIPs (10), with
chromatin of 0.8 kb and with anti-YB as well as anti-YC purified
polyclonal antibodies. The sequence of PCR primers used to analyze the
genes reported in Fig. 2 are shown in Supplemental Table I.
Generation of ChIP Probes
DNAs from 20–30 individual ChIPs were used to generate a probe for
array screening. Immunoprecipitated chromatin was used as template
for random priming reactions in the presence of 10 mM amino allyl-UTP
(Sigma catalog no. A-0410) using the BioPrime DNA labeling system
(Invitrogen). The DNAs were desalted and concentrated with a Micro-
con YM30 filter column (Millipore Corp.) and then lyophilized. After
resuspension in water, amino allyl-dUTP-labeled chromatin was cou-
pled with Cy5 dye (Amersham Biosciences) solubilized in 0.1 M sodium
bicarbonate, pH 9.0, for 1 h in the dark. After the addition of 0.1 M
sodium acetate, pH 5.2, DNAs were purified with QIAquick columns
(Qiagen) and lyophilized.
Amplicon Generation and Labeling
The generation of amplicons from individual ChIPs was performed
following the protocols of LM-PCR described in Refs. 20 and 21. Briefly,
two unidirectional linkers (oligonucleotide JW102, 5-GCGGTGAC-
CCGGGAGATCTGAATTC-3; oligonucleotide JW103, 5-GAATTCA-
GATC-3) were annealed and ligated to the chromatin IPs, previously
blunted by T4 DNA polymerase. The first amplicons were generated by
PCR (one cycle at 55 °C for 2 min, 72 °C for 5 min, 95 °C for 2 min,
followed by 15 cycles at 95 °C for 30 min, 55 °C for min, 72 °C for 1 min,
and a final extension of 4 min at 72 °C). The reaction was purified using
the Qiaquick PCR purification kit (Qiagen) or the GFX PCR purification
kit (Amersham Biosciences) according to the manufacturer’s instruc-
tions. One-tenth of these initial reactions were used to generate more
amplicons, using the same PCR program for a subsequent 30 cycles.
After purification of these last rounds of amplification, the DNA was
quantified and examined by gene-specific PCR to ensure that the initial
enrichment was maintained. 5 g of amplicons for -NF-YB, -FLAG,
and input DNA (subjected to the same number of PCRmanipulations as
the IPs) were labeled using the LabelIT Cy5/Cy3 nucleic acid labeling
kit (Mirus), following the manufacturer’s instructions, with a reagent/
DNA ratio of 2.5 for Cy5 (IPs) and 1.5 for Cy3 (input).
CpG Microarray Hybridization
7776 CpG Array—The development of the 7776 CpG island array
was described previously (21–23). Prior to hybridization, spotted CpG
island slides were incubated with a solution of 3 SSC, 0.25% SDS, and
1.5 g/l salmon testis DNA under a glass coverslip at 37 °C for 30 min
to block nonspecific binding. Slides were washed twice with water and
dried for 5 min at 600 rpm in a centrifuge. Labeled DNAs were added to
hybridization buffer (0.25 M NaPO4, 4.5% SDS, 1 mM EDTA, and 1
SSC), denatured at 95 °C for 2 min, cooled to 60 °C, and dropped onto
slides placed in prewarmed hybridization chambers. Incubation was
performed at 60 °C overnight. After hybridization, the slides were
washed successively at 50 °C with 1 SSC, 0.1% SDS at room temper-
ature with 1 SSC (0.1%) and at room temperature with 0.2 SSC for 5
min each and then dried. Hybridized slides were scanned with the
GenePix 4000A scanner (Axon), and the acquired images were analyzed
with the software GenePix Pro, Version 3.0. A global normalization
factor was determined for each replica, evaluating the anti-NF-YB
ChIP Cy5/control ChIP Cy5 ratio relative to control repetitive elements.
Data were normalized prior to comparison. After normalization, posi-
tive loci were defined by hybridization intensities at least 2 times
greater than that of control.
12K Array—The Cy5- and Cy3-labeled DNA were each resuspended
in 10 l of 1 g/l Cot-1 DNA (Invitrogen) and mixed together in order
to have the same amount of input Cy3-labeled DNA for each IP Cy5-
labeled DNA. The hybridization solution was then added to a final
composition of 43% formamide, 4.3 SSPE, 0.42% SDS, 42 g of salmon
sperm DNA, 0.2 g of tRNA, heated for 2 min at 95 °C and cooled down
to 37 °C over 30 min. 95 l of each mixture solution was applied to two
human CpG 12K slides (University Health Network, The Microarray
Center, Toronto, Canada) and hybridized at 37 °C for 18 h. The slides
were prehybridized for 1 h at 42 °C with 25% formamide, 5 SSC, 0.1%
SDS, and 10 g/l bovine serum albumin.
The slides were washed at room temperature for 5 min twice in 2
SSC, 0.1% SDS; once in 1 SSC, 0.1% SDS; and one final time in 0.1
SSC; dried; and immediately scanned using a ScanArray 4000 scanner
(Packard). The hybridized microarrays were analyzed using the Quan-
tarray microarray analysis software (Packard). Features of poor inten-
sity (500) and those that did not meet the quality control criteria
(visual inspection, spot circularity, spot uniformity, and background
uniformity for both channels) were discarded. After the background
subtraction for each spot, the data were normalized to median (i.e. the
ratio of the median value of all spots in the Cy5 channel (IP DNA) was
normalized to the ratio of the median value of the control channel
(Cy3  input)). From a direct comparison of the arrays hybridized with
the DNA of the -NF-YB IP and the -FLAG IP, only the spots that
showed an enrichment 2-fold in the YB samples were further ana-
lyzed. Two independent experiments were performed, each consisting of
one -NF-YB IP and one control -FLAG IP slide, normalized to the
same input DNA, and the commonly enriched spots were considered.
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Positive clones were sequenced and mapped with BLAT. The pres-
ence of CCAAT sequences were searched for 2 kb on the flanking of the
7776 CpG island array and 500 bp on the 12K array, annotated in
individual files corresponding to the genomic loci identified. The criteria
for classifications are described below. Mouse orthologs were retrieved
using BLAT. The annotated genes were classified according to func-
tional categories, and the classification was compared with those per-
formed on the MYC and E2F4 targets.
Expression Analysis of NF-Y-targeted Genes
HepG2 cells were infected with control green fluorescent protein,
wild type NF-YA, or dominant negative YAm29 adenovirus.2 Adenovi-
rus vectors to express NF-YA or the YAm29 dominant negative mutant
were generated using AdEasy, using HindIII and XbaI from the corre-
sponding pcDNA3-based vectors, and introduced into the same sites of
the shuttle vector pAdTrack-CMV. This plasmid was recombined with
the vector pAdEasy1, followed by treatment with PacI and transfection
into an E1-complementing cell line. We infected exponentially growing
cells for 7 h in the absence of serum. Fetal calf serum was then added,
and cells were incubated for 48 h. RNA was extracted using an RNA-
Easy kit (Qiagen), according to the manufacturer’s protocol. For cDNA
synthesis, 4 g of RNA were used with the M-MLV-RT kit (Invitrogen).
Semiquantitative PCR analysis was performed with oligonucleotides
detailed in Supplemental Table II.
Electrophoretic Mobility Shift Analysis of NF-Y Binding
EMSA analyses of Fig. 3 were performed under standard NF-Y
conditions (6, 11, 22, 23), with anti-YB supershift antibodies and re-
combinant NF-Y and the indicated oligonucleotides. 32P-Labeled oligo-
nucleotides were incubated in 20 mM Tris-HCl, pH 7.8, 50 mM NaCl, 1
mM dithiothreitol, 3% glycerol, 5 mM MgCl2 for 30 min at 20 °C with 5
ng of recombinant NF-Y trimer or with 5 g of HepG2 nuclear extracts
together with 200 ng of poly(dI-dC) (Sigma). The samples were loaded
on a 4.5% polyacrylamide gel, run for 2 h, dried, and exposed. To
produce recombinant NF-Y, Escherichia coli BL21 DE3LysS was in-
duced at an A600 value of 0.6 by the addition of isopropyl--D-thiogalac-
topyranoside to a final concentration of 1 mM for 3 h. Bacterial pellets
were resuspended and sonicated in sonication buffer (150 mM KCl, 20
mM Tris-HCl, pH 7.8, 0.05% Nonidet P-40, 0.1 mM EDTA, 5 mM 2-mer-
captoethanol, 1 mM PMSF (Sigma), and protein inhibitors) and centri-
fuged at 23,000 g in a Beckman SW 27Ti rotor for 30 min at 4 °C. The
inclusion bodies pellet was resuspended in sonication buffer, sonicated,
and centrifuged again. Inclusion bodies were finally resuspended in 6 M
guanidium chloride, 20 mM sodium acetate (pH 5.2), 5 mM 2-mercapto-
ethanol, and 1 mM PMSF. The three subunits were mixed to a final
concentration of 0.5 mg/ml and dialyzed against a 100-fold excess of
BC300 (300 mMKCl, 20 mM Tris-HCl, pH 7.8, 0.05%Nonidet P-40, 5 mM
2-mercaptoethanol, 1 mM PMSF); glycerol concentration was adjusted
to 20%, and proteins were loaded on a nickel-nitrilotriacetic acid-agar-
ose column, washed with BC300, and eluted with 0.25 M imidazole. The
proteins were finally dialyzed against BC100, the purity being routinely
80%.
RESULTS
Our goal was to identify novel targets of NF-Y in an unbiased
way. The combination of chromatin immunoprecipitation with
microarray analysis was performed in yeast (24–26) and hu-
mans (20, 27–30). In particular, DNA microarrays containing
genomic fragments with CpG islands, often corresponding to
regulatory regions, were probed with DNA recovered from
chromatin immunoprecipitated using MYC, E2F4/6, and
methyl CpG binding domain protein antibodies. We decided to
take the same route and used two different reagents: a 7776
array and a 12K array from UHN (Toronto, Canada). We also
tested two different ways of preparing probes for hybridization.
For the 7776 array, we prepared several sequential ChIPs with
chromatin from the liver HepG2 cell line, with a highly specific
anti-NF-YB antibody, and, in parallel, control ChIPs with a
commercially available anti-FLAG control. The chromatin used
in this procedure was larger (2–2.5 kb) than the one used in
conventional ChIPs (0.5–1 kb). Because of the modifications of
our routine ChIPs with extended chromatin, we first verified
whether immunoprecipitated DNAs were indeed enriched in
NF-Y-targeted fragments. We used oligonucleotides amplify-
ing several CCAAT-containing promoters in semiquantita-
tive PCRs. Fig. 1A shows that essentially all of the promoters
tested were clearly positive in the anti-YB ChIP, compared
with the FLAG and no antibody controls: the liver-specific
genes GA, MVK, OAT, and mATP synthase and the ubiqui-
tous HnRNPA1, NP95, PPP1R7, HMGB2, ABL, CDC25A,
-actin, and OGG1. Note that only the last two genes were
previously known to be regulated by NF-Y (31, 32), whereas
all of the others were derived from a CCAAT-containing
promoter data set.3 In parallel ChIP analysis, CCAAT-less
promoters, p107, -tubulin, RPS19, and YBL1, were negative
(Fig. 1A, lower panel).
For the 12K hybridization, we took a different approach, by
PCR-amplifying chromatin from Nalm-6 cells after ligation of
linker DNA. The advantage is that a very limited amount of
ChIP material is required to yield enough DNA for hybridiza-
tion. We also checked that the successive rounds of PCR am-
plifications would not decrease the enrichment of bona fide
2 Imbriano, C., Gurtner, A., Cocchiarella, F., Di Agostino, S., Basile,
V., Gostissa, M., Dobbelstein, M., Del Sal, G., Piaggio G., and Man-
tovani, R. (2005) Mol Cell Biol., in press 3 A. Testa and R. Mantovani, manuscript in preparation.
FIG. 1.Validation of the NF-YB probes for the ChIP on chips. A,
analysis of NF-Y targets with DNA immunoprecipitated with the
“extended chromatin” ChIP protocol from HepG2 chromatin. In the
upper panels, genes predicted to be targeted, according to the CCAAT
promoter data set (F. Romani and R. Mantovani, unpublished observa-
tions). In the lower panel, bona fide CCAAT-less promoters were as-
sayed. B, the NF-YA gene promoter was PCR-amplified from NALM-6
chromatin ChIP (upper panel) and after the LM-PCR amplification
procedure for probe preparation (see “Experimental Procedures”).
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NF-Y targets in the amplicons. Indeed, Fig. 1B shows that the
NF-YA promoter amplicon is no less, and in fact probably more,
enriched in the final LM-PCR chromatin compared with the
initial starting material. Therefore, we conclude that both of
these procedures yield sufficiently enriched DNA for further
genomic analysis.
Results of the 7776 Array—We used DNAs from 20–30 indi-
vidual ChIPs to generate probes for the 7776 array screening.
We identified at least 230 spots, in which the corrected signal
obtained with the NF-YB chromatin was at least 2-fold higher
than the anti-FLAG signal. We sequenced all positive clones
and derived their chromosomal localizations. A positive clone
will indicate that a bound NF-Y site lies somewhere within 2.5
kb of the CpG island. The genomic sequences surrounding the
CpG island were therefore scrutinized for the presence of
CCAAT sequences for a length of 2 kb on either sides. Table I
shows a list of the positive clones. Several criteria helped us to
classify them as follows.
Flanking sequences are essential for high affinity NF-Y bind-
ing both at the 5 and 3 of the pentanucleotide, with a varia-
tion of 2 logs in Kd in vitro, between high and low affinity sites
(for details, see Refs. 6, 7, 11, and 23). In essence, functional
low affinity CCAAT boxes are rare and mostly found in prox-
imity of high affinity ones. We classified as high affinity those
NF-Y sites having optimal sequences both at the 5 and at the
3 of the pentanucleotide ( in Table I); medium affinity
those with optimal nucleotides at the 5 or 3 end ( in Table
I); low affinity those only harboring the CCAAT pentanucle-
otide ( in Table I). In most clones, multiple CCAAT boxes
were identified, with various degrees of consensus match; in
these cases, we referred only to the highest affinity ones.
We singled out the clones with a location appropriate for a
“promoter” definition (i.e. whenever a mapped known gene or
multiple clustered expressed sequence tags generated from a
localized area were nearby). This is because the CCAAT posi-
tion is quite constant, 60–100 bp from the transcriptional start
site within the promoters analyzed (7), and exceptions to this
rule are sporadic (32–34). In all cases in which multiple CCAAT
boxes were detected throughout the locus, the clone was clas-
sified as “canonical” if one of them was present in the promoter,
within 200 bp from the transcriptional start sites.
We further separated the promoters into two categories,
based upon the type of transcriptional unit. CpG islands are
abundant not only in simple promoters but also in divergent,
convergent, and tandemly linked promoters as well (18, 35); we
collectively classified them as complex transcriptional units
(CTUs).
Species conservation of TF target sites or regulatory regions
in general (and of CCAAT boxes in particular) is a hallmark of
functional importance, as detailed in transfection experiments
and phylogenetic footprints. We thus retrieved information of
the mouse orthologous genes and analyzed them for the pres-
ence of a CCAAT sequence at the corresponding position. This
could only be possible, with a good degree of confidence, for the
promoter (canonical and CTUs) data set, by taking the tran-
scriptional start site as the pivotal point. The sequences of all
of the loci are individually provided as Supplemental Table III.
In all clones retrieved, at least one CCAAT pentanucleotide
could be found. This is well expected, given the 4–5 kb of DNA
analyzed on both sides of the CpG clones and the average
frequency of the core CCAAT (or ATTGG) pentanucleotide, one
every 0.5 kb. However, a consensus high affinity NF-Y site
( in Table I) is theoretically present every 16 kb (7). Given
the overall length of DNA analyzed in all of the loci (750 kb),
the total number of CCAAT boxes expected would be 1500, with
46 high affinity ones. Indeed, 1135 CCAAT were scored, with
252 of these matching the NF-Y consensus; thus, although
there is a slight negative skewing for the pentanucleotide
around the CpG island regions analyzed, the NF-Y optimal
sites were 6-fold overrepresented.
To validate our analysis, we performed conventional ChIPs,
with 1 kb of chromatin. Selections of the identified targets in
each of the different classes were probed with anti-NF-YB and
NF-YC antibodies. Furthermore, we also performed sequential
immunoprecipitations of chromatin with both antibodies (re-
ChIP). The results of these experiments are shown in Fig. 2. All
targets tested scored positive, further confirming that clones
emerging from the ChIP on chip analysis are indeed positive for
NF-Y binding in vivo.
Results of the 12K Array—Table II contains the genes that
emerged from the 12K array screenings with the anti-YB
probes. The criteria mentioned above for the classification were
also applied here, except that the flanking DNA considered was
shorter (1 kb) due to the restricted length of the probe. Clones
showing 2-fold higher signals with respect to the FLAG con-
trol were 1205 and 783 on 5121 and 4371 spots analyzed,
respectively, corresponding to 23 and 18% of positivity. 119
clones were in common; of these, 65 clones were mappable
based on the sequences retrievable from the Sanger Centre.
Core promoters were 10%, and noncanonical CCAAT were
nearly 50%. Several CTUs were also present. Overall, the dis-
tribution was highly reminiscent of the 7776 array. Here,
again, we validated selected clones by conventional ChIP; all
showed a substantial enrichment with respect to the FLAG
control (Fig. 2A, right panels).
Analysis of NF-Y Targets—To pinpoint specifically the sites
of interactions, we performed in vitro EMSAs with HepG2
nuclear extracts and oligonucleotides corresponding to selected
CCAAT boxes found in the CpG island regions of the HepG2
targets. Fig. 3 shows that essentially all CCAAT boxes are able
to interact with a binding activity in nuclear extracts. This is
identified as NF-Y by (i) supershift with the diagnostic anti-YB
antibody and (ii) association with recombinant NF-Y. There-
fore, we conclude that the identified targeted genes do contain
NF-Y binding CCAAT boxes.
To further check whether the predicted CCAAT boxes were
correctly evaluated, we performed ChIP scanning experiments
on three loci. We immunoprecipitated chromatin from HepG2
with anti-YB and anti-YC antibodies and amplified three dif-
ferent regions of the CDKN2A-MTAP and EMX2-EMX2OS
CTUs and the canonical PMSC6 gene. Results shown in Fig. 4
indicate that only one amplicon of the CDKN2A-MTAP loci was
positive with both NF-Y antibodies, corresponding to the 
CCAAT box indicated in Table I, despite the presence of other
CCAAT elements in the proximity of the negative amplicons. In
the case of the EMX2-EMX2OS locus, amplicons 2 and 3 were
positive, corresponding to the core promoter regions of both
genes, whereas an amplicon in the proximity of two high affin-
ity sites in an intronic region of EMX2OS was not enriched
compared with the control. In the PSMC6 locus, only the high
affinity core promoter CCAAT was bound in vivo. Collectively,
these experiments support the classification of Tables I and II
and suggest that the genes are indeed under NF-Y control.
Function of NF-Y on Selected Targets—To verify the role of
NF-Y binding in the expression of the newly discovered genes,
we used adenoviral vectors expressing wild type NF-YA and
the well characterized dominant negative YAm29 mutant, ca-
pable of associating to the histone fold motif dimer but crippled
in the DNA-binding subdomain and hence incapable of binding
to the CCAAT box. HepG2 cells were used for the infections,
and mRNA analysis of a number of target genes retrieved from
the 7776 array was performed by semiquantitative reverse
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Classification of NF-Y-targeted genes
NF-Y-targeted genes are classified according to three categories (canonical, noncanonical, and complex transcriptional units) and to the relative
match to a consensus NF-Y-binding site (, perfect match; , mismatch at the 5 or 3  mismatches at the 5 and 3 , no match). The
presence of a CCAAT sequence in the mouse orthologs is indicated, as well as the locus link or accession numbers. In the noncanonical CCAAT
cohort, we indicated whether a CCAAT was present in introns (in), or at the far 5 (up) or 3 (do) ends of the gene.
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transcription-PCR. The results are shown in Fig. 5. The control
YBL1 transcript generated by a CCAAT-less promoter was
unchanged (Fig. 5, bottom panel). All other loci were variously
affected; in some cases (CDC10, BET1, and EMX2), the effect of
the YAm29 was relatively modest with respect to the controls.
For other genes, reduction was quite severe; expression of
TIMP3, MTAP, TIP-1, and SHOX2 was nearly abolished. We
also analyzed two complex loci. In the TYMS-s.FLJ147447
divergent units, both mRNA were affected, albeit modestly; in
the TLP19 locus, in which the CpG island is located between
exons 2 and 3, we analyzed three transcripts: in addition to
TLP19, the convergent SBBI18, generated just upstream from
the CpG island, and the divergent FLJ14844, which starts far
upstream. Interestingly, the TLP19 and SBBI18 were severely
affected by YAm29, whereas FLJ14844 was not. Taken collec-
tively, these data confirm that the targeted genes are indeed
affected by inhibition of NF-Y activity and that CTUs can be
regulated simultaneously.
DISCUSSION
The results of the ChIP on chips analysis presented here
represent a major and unexpected advance in our understand-
ing of NF-Y genomic strategy in two specific directions: the
identification of a high proportion of CTUs and of NF-Y sites
away from promoters found in introns or at distant 3 or 5
locations.
The number of NF-Y-regulated genes found in our analysis is
more in line with the 7.6% figure recently obtained by Fitzgerald
et al. (2); in fact, were NF-Y indeed involved in themajority (67%)
of promoters, as suggested by Suzuki et al. (1), we would expect
a much larger number of positive clones. However, several
considerations can be put forward to explain the relative pau-
city of isolated targets. (i) In the 7776 CpG experiments, we
applied a stringent cut-off by normalizing for the higher signals
observed with anti-YB DNA in clones containing repetitive
sequences; recent reports, however, suggested that CCAAT
boxes are present and conserved in some families of repetitive
DNA of retroviral origin (36). This finding matches the well
known importance of NF-Y sites in many (actually most) ret-
roviral long terminal repeats (reviewed in Ref. 7).4 Thus, our
normalization is likely to have obscured a larger set of targets.
(ii) It is likely that only a minority of genes are expressed at
high levels in all cells and hence activated by NF-Y at all times.
Many of the ubiquitous genes, in fact, are only active under
specific circumstances (stress, apoptotic signals, a specific cell
cycle phase, or environmental stimulus). Cell cycle promoters,
for example, to which NF-Y association fluctuates considerably
(10), are potentially underrepresented; indeed, other anti-YB
positives, such as cyclin B1, that scored between 1.5 and 2 in
fluorescence intensity above the FLAG control in the 7776
array are bona fide NF-Y targets.5 (iii) In similar ChIP on chip
experiments, an equivalent number of clones were retrieved for
MYC (28) and fewer for E2F4, E2F6, and methyl CpG binding
domain proteins (20, 27, 30). Alternative approaches indicate
that MYC high affinity sites are only a part of the overall
binding strategy (37). Thus, it is likely that our data constitute
a fraction of all of the potential NF-Y targets. (iv) Most impor-
tantly, only clones that showed positivity for multiple hybrid-
izations were considered. In the case of the 12K array, positiv-
ity was scored in 15–20% of clones of the individual
4 G. Donati and R. Mantovani, unpublished results.
5 A. Testa and R. Mantovani, unpublished results.
FIG. 2. Validation of the positive
clones. A, conventional ChIP analysis
(upper panels) of several NF-Y targets
from the HepG2 screening with the anti-
YB, anti-YC, and control antibodies. In
the right panels, positives from the
Nalm-6 screening were validated with the
anti-YB antibody. B, sequential ChIPs
were performed with the indicated anti-
NF-Y antibodies or with the controls. De-
tails on the oligonucleotides used are
shown in Supplemental Table I.
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experiments, yet only 119 of them overlapped. We believe that
suboptimal hybridization conditions prevent the successive and
reproducible identification of the same set of targets, preclud-
ing the possibility of calculating the exact number of NF-Y-
targeted loci. These shortcomings notwithstanding, our data
lead to several interesting considerations.
Conservation of NF-Y Sites—Among the identified genes,
only four were previously established through mutagenesis of
CCAAT, but not by ChIP analysis: (i) the UNG2-UNG1 tan-
demly linked genes were functionally dissected, and CCAAT
boxes were found to be of importance for both genes (38); (ii)
TIMP2 (and the related TIMP1/3) are clearly under NF-Y
control (39–42); (iii) proliferating cell nuclear antigen, a CTU
in which the CCAAT box is found in the first intron (43); and
(iv) MTAP, a gene in which two separated suboptimal CCAAT
boxes are important (44). For others, NF-Y-binding was more
than suspected. (i) The divergent promoters of the H2B-H3 and
of H2A-H4 loci belong to the wide family of histone genes;
detailed mutational analysis of other histone promoters clearly
evidenced the importance of NF-Y (45, 46). (ii) Functional anal-
ysis of the NKX6.1 promoter pointed to a double CCAAT region
as essential (47). (iii) PAX2 and TLP19 belong to gene families
for which formal proof of NF-Y involvement was obtained with
other members: PAX3/7/8 (48–50) and other endoplasmic re-
ticulum stress-inducible genes, respectively (51–53). The anal-
ysis of the conservation between human and mouse promoters
represents a good example of phylogenetic footprint, since 52 of
72 (74%) mouse orthologous promoters do contain CCAAT at
the expected position; this percentage increases to 86% if we
consider the optimal NF-Y sites (Tables I and II). Thus, the
notion that conservation of the CCAAT is an integral part of
the expression strategy within gene families and across species
is reinstated.
The CCAAT Box and Complex Transcriptional Units—It is
somewhat surprising to find a high frequency of CTUs in our
analysis; 24% of the loci analyzed contained bidirectional pro-
moters, and 15–17% contained tandem promoters. Most bidi-
rectional promoters are divergent (60%), and the rest are con-
vergent, generating partially overlapping transcripts. This
result was not anticipated; previous data identified only a
minute number (essentially histones, UNG1-UNG2, and AIRC-
GPAT) actually containing such units (7).6 An unexpected
abundance of bidirectional promoters in the human genome
has recently been documented; as many as 11% of the total are
divergent, either with overlapping or nonoverlapping tran-
scripts (35, 54). Furthermore, the bidirectional arrangement is
often conserved among mouse orthologs and important for ex-
pression of both transcripts. We analyzed the ChIP on chip
experiments previously performed on the 7776 array, obtaining
figures of 15% for E2F4 and 23% for MYC targets as bidirec-
tional promoters (27, 29). This suggests that (i) MYC and NF-Y
sites are enriched in bidirectional promoters and/or (ii) that
CpG islands are indeed specifically abundant in such units.
CCAAT-less bidirectional promoters, do exist (e.g. the YBL1
promoter analyzed in Figs. 1 and 5); NF-Y, therefore, cannot be
considered as a hallmark for such units. Nevertheless, in all
systems tested so far, centrally located CCAAT boxes are im-
portant for the expression of divergent genes (45); the data
obtained with the dominant negative NF-Yam29 presented in
Fig. 5 on the TYMS and TLP19 loci confirm this assumption.
The biological significance of the higher frequency of complex
CTUs regulated by NF-Y as well as the molecular details of
divergent co-regulation require further dissection.
CCAAT at Distant Locations—A second unanticipated re-
sult is the abundance (40–50%) of sites away from promoters,
with almost half of them located in introns. This clearly
means that NF-Y is not a promoter-specific factor. It is im-
6 R. Mantovani, unpublished results.
TABLE II
NF-Y-targeted genes in Nalm-6 cells are classified according to same criteria used in Table I
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portant to emphasize that this finding would have been com-
pletely obscured had we used a promoter array chip, as avail-
able information on CCAAT locations would have suggested.
Of course, the assumption that the CCAAT box was almost
exclusively a promoter element was based upon standard
promoter-driven analysis, thus merely reflecting the fact that
FIG. 3. Identification of NF-Y-bind-
ing CCAAT boxes. Shown is an EMSA
analysis of CCAAT boxes of genes regu-
lated by NF-Y, as in Fig. 4. Labeled oligo-
nucloetides, depicted for each target, were
labeled and incubated with 5 g of HepG2
nuclear extract alone or in the presence of
anti-YB supershifting antibody. Recombi-
nant NF-Y (1 ng) was incubated in paral-
lel. The different electrophoretic mobility
of the latter is due to the presence of a
thioredoxin moiety in the NF-YC subunit.
FIG. 4. ChIP scanning of NF-Y bind-
ing to CCAAT boxes. ChIP analysis of
HepG2 chromatin with the indicated an-
tibodies was performed on three different
loci. Different amplicons, as indicated in
the schemes, were amplified and shown in
the upper panels.
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far greater information had been gathered from such se-
quences. Only a handful of cases of distant locations were
previously described. (i) In the major histocompatibility com-
plex class II genes, upstream enhancers were shown to be
dependent upon Y-boxes and neighboring RFX-binding sites
(34). (ii) Sequences were found in the HOXB4 gene, that
contain a highly conserved NF-Y site in a crucial intronic
enhancer (in fact, it is not even a perfect pentanucleotide,
CCATT or GCAAT), and similar deviant sequences were no-
ticed at corresponding locations in other introns of HOX gene
clusters (33). Interestingly, CCAAT boxes exist in HOX gene
promoters as well (55–57), one of which (HOXB13) was iden-
tified here; they are perfect CCAAT, whereas the intronic
ones are modified, most likely to accommodate the binding of
additional cooperating factors, as shown for YY1 in the case
of HOXB4 (33). This suggests that there might be a plethora
of specialized CCAAT versions, slightly deviating from opti-
mal sites. It is even possible that we are largely underesti-
mating the number of binding sites by focusing on the perfect
pentanucleotide. NF-Y binding has been so far invariably
associated with regulatory regions, which is confirmed by the
expression analysis with the dominant negative NF-Yam29
shown here. An important implication of our data, therefore,
is that new enhancers or regulatory regions could be uncov-
FIG. 5. Functional importance of NF-Y binding for target genes expression. Shown is semiquantitative reverse transcription-PCR
analysis of mRNAs extracted from HepG2 cells uninfected or infected with control green fluorescent protein (GFP) adenovirus or with adenovirus
producing wild type or the DN YAm29 mutant, respectively. The unaffected CCAAT-less YBL1 transcript was used for mRNA normalization.
Details on the oligonucleotides used are shown in Supplemental Table II. The positions of the CCAAT boxes are marked by circles ( (light gray),
 (gray), and (dark gray)), positions of exons are marked by black boxes, positions of the hybridizing CpG island clones are marked by white
boxes, and positions of transcripts are marked by arrows.
FIG. 6. Functional classification of NF-Y target genes. The
genes targeted by NF-Y whose function is known or inferred were
classified according to the function of the encoded protein.
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ered via this strategy. In vivo functional dissection of the
distant regions isolated here with enhancer-based assays is
necessary to establish this point.
Functional Classification of NF-Y Targets—Fig. 6 shows the
functional classification of the annotated genes. In both HepG2
and Nalm-6, prominent classes are (i) DNA-binding and tran-
scription factors in general, which represent 25% of the total,
and (ii) membrane/extracellular matrix proteins coding genes
and signal transduction genes. Far fewer genes code for struc-
tural proteins, proteins involved in mRNA processing and in
vescicular and nuclear trafficking. This could be due to partic-
ular skewing of the CpG library (16), but we note that many of
the genes identified in both HepG2 and Nalm-6 are indeed
important for cell growth.
An important corollary to this analysis is the identification of
genes that are targeted by NF-Y and MYC/E2F4. LALP1,
MRS3/4, GTF2H2, and EIF3S8 are shared with MYC; CSDA,
RAD51, TYMS, and D1S155E are shared with MYC and E2F4.
Thus, new transcriptional networks can be constructed; this is
particularly relevant, since NF-Y is known to be cooperating
with E2Fs in many systems (58) and to be controlled by MYC
through direct protein-protein interactions (59). A precise map-
ping of the E2F and MYC regulatory areas, possibly adjacent to
CCAAT boxes, as well as functional co-expression experiments,
should provide a clue for their coregulation.
In conclusion, although we are still far from having a com-
plete map of NF-Y targets on hand, the criteria employed here
reveal new twists in the genomic strategy, mainly concerning
its role in complex units and at nonpromoter locations. To build
a complete understanding of the transcriptional networks in
which the trimer takes part, it will be important to widen the
analysis to lower affinity sites, in different cell types, under
various growth conditions and with various partner activators.
Acknowledgment—We thank L. Penn for many helpful discussions.
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Supplementary 1  
   
List of Chip oligonucleotides.  
   
   
HOXB13 5'cttgcgagctgggagcgattta3'  
 5'cccagcaagccttcgatatcct3'  
CDKN2A 5'ggctagacacaaaggactcggt3'   
 5'caggaacagccgcgctcc3'     
PGM3 5'ggcccgcatccccctctc3'     
 5'ggctccggacgtttacgattcact3'    
SALL4 5'cttctcggctggtggacatc3'     
 5'ctccgccacaaattcctggag3'     
D1S155E 5'gttccttgaggacaagtctatatccg3'    
 5'gagatgattcatccaatgggggaag3'  
CSDA 5'ccttgtcagctgcgggtgtc3'     
 5'agggcgggcgaggggaga3'     
BET1 5'agcgggaacgttggatcagagac3'    
 5'agggcccagcgaaacaccaactt3'    
EMX2 5'ccctcactccaggatccctc3'     
 5'ggcttgatgattggtcgctattactc3'    
PSMC6 5'cccgggaggtggaggttgc3'   
 5'gggtgggggttgtgggtagaaa3'  
BCAA 5'gaggccatccgggaaagaggta3'   
 5'ggggagggggacgacgaaaaat3'  
ZF6 5'ctcagggcgcgcttttaagg3'  
 5'cgagccctcattggctctga3'  
TLP19 5'gatgagggaagccaatggtcaa3'  
 5'ccaggccttgggtttacagcat3'  
SHOX2 5'gggaggattccccatctgacac3'  
 5'aactatccccacacaggcagca3'  
SDF2 5'atggtaattggagagggatgtgaa3'    
 5'taccgtctggagaggcttagt3'     
MTPN 5'caggcatgagccactgcac3'   
 5'agtcagttctgttcttcctagggt3'    
TA-KRP 5'cgacggccacaggctgg3'     
 5'caccacacgacccacctgc3'   
TYMS 5'ccgacaggagcaccccag3'     
 5'ggtccgtgggccggag3'  
RFC3 5'agaccttgcaatcaaatggcagga3'    
 5'gcgtcgatgccctctagttc3'   
α Galactosidase A 5'actcgggatcactaaggtgccg3'  
 5'ccggacagcataaatttccgcg3'  
MVK 5'cacagctggccgcgccacc3'  
 5'cagagcgcccgtgcctcaag3'  
OAT 5'gctcaggaggcgcgaggcg3'  
 5'ggtacctgacagcgcctgag3'  
mATPsynthase β 5'acaggaactcggcccctttcct3'  
 5'gcgtagtccgggtggagactg3'  
OGG1 5'cggagtgcagacaatcccgg3'  
 5'ctccttgcgacttatcttctcc3'  
NP95 5'ccgcgattcaattgtcgcgcc3'  
 5'ccctggaccctcggcgtcc3'  
PPP1R7 5'gcggcctcatgacggaactac3'  
 5'actgttgctgccccgcgccg3'  
CDC25A 5'cttctgctctgggctccgcc3'  
 5'caagccgacctacacctcttac3'  
HMGB2 5'cagccccaaccagtcagcgtg3'  
 5'cccaacggagacgcttccctc3'  
hnRNP A1 5'catgctttgccaagcgacttgac3'  
 5'ggagcaagctgacgaacgtatc3'  
β actin 5'caccccaaggcggccaacgc3'  
 5'cgcgtcgcgccgctgggttt3'  
ABL 5'cacacgccacacaacgtgag3'  
 5'ccaatgagttgcgcaggcgc3'  
p107 5'tacacctcccagcaggctctg3'  
 5'ctcccaggcgcgctacccac3'  
α tub 5'gccgttgggtggagtcagcg3'  
 5'cagaaagtggcccctcagcat3'  
HMGB1 5'tcagcctctttgcccggcatac3'  
 5'gtgagagcgggagccagacg3'  
RPS19 5'ccaggcctccacgcgcgac3'  
 5'cagctcggagcccccgcttac3'  
YBL1 5'gcctgcctcgggtcctaaaggg3'  
 5'ggtctgaccctgcgaggtttccgtt3'  
TEGT 5'agccaatggaaaggcaggagt3'  
 5'catctgtccgcagaaggaagc3'  
MLL5 5'tttgcaacagcctccccctac3'  
 5'cgagggagggacagacagtga3'  
HES7 5'atctttaagccgcgcattggt3'  
 5'ctggggctgcaaactctgcta3'  
c6orf170 up 5'gatatgccaagtcggtgctgtg3'  
 5'cgaatcccttaacgtgccaaaa3'  
PCNA 5'aaccggttacctccagaaccag3'  





List of RT-PCR oligonucleotides. 
 
 
CDC10F GAG GAG AGG AGC GTC AAC AGC    
CDC10R GAT ACT GCC TTC CTC TGA CCC T    
TIMP3F TCG GGC TCA TCG TGC TCC TGG G   
TIMP3R GAT ACC GAT AGT TCA GCC CCT TGC G  
BET1F CTG GCA ACT ATG GGA ACT ATG GC    
BET1R GCT TTG TTT GGC TCC CTC TGG    
Znf6F CCT GGG TTG TTG GTG TGG AGT G   
Znf6R TGC TGA TGT TGA ATG AGG CTG CTC    
MTAPF ATT GAC AGG ACC ACT ATG AGA CC    
MTAPR TCT TCA GGT TAT GGA GGG TTT CT    
PGM3F CCT GGT GGA GAT TGG AGA AAG TTT G   
PGM3R CCT GGG GGT GTA ACT GCT TGT C   
TIP1F GAA GAC AAG ACG GAC AAG GGT ATT TAT G    
TIP1R CAG ACG CAC CAC CTC CTC CGA   
EMX2F GCC CCA TAA ATC CGT TCC TCA ACG   
EMX2R CAT ACT TTT ACC TGA GTT TCC GTG AGG   
SHOx2F CCG AGT GCA GGT TTG GTT TCA   
SHOx2R ATG CTG GAG TTC TTG CTG GTG    
SLC8A2F TCA AGG GGA TGG GGA CAG GAA    
SLC8A2R GGC GAA GAG GAT GTA CAG GAG    
TPL19(ERp19)F TCG TCT CGG GGC CAC CTG TTT G   
TPL19(ERp19)R CAT CCC CTG AAC AAC TTG CTC GG    
SBBI80(TPL19locus)F CCG CTC TGC CTG GTC TAC TGC    
SBBI80(TPL19locus)R GCG TAG ACT GAT GGG GTG GTG G    
FLJ14844(TPL19loc)F GGG GCA AGG GTA CAG CTC GC   
FLJ14844(TPL19loc)R GCA TTT CTG TGA TTG GTT TGG CTT CTG C  
TYMSF CAA GGG ATC CAC AAA TGC TAA AGA G    
TYMSR TGT GCA TCT CCC AAA GTG TGT ATA AAG   
sLOC147447(TYMloc)F GCT GGG ACG CGG CTT ACC TCC    
sLOC147447(TYMloc)R TCA GGA AGG ACG ACC GCA CGG G   
 
FIGURE LEGEND.
+++ CCAAT boxes are indicated in Red.
++ CCAAT boxes are indicated in Orange.
+ CCAAT boxes are indicated in Yellow.
Primers used for CHIP validations are in Blue.
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